OptiNose Statistics
Total Valuation
OptiNose has a market cap or net worth of $97.22 million. The enterprise value is $151.49 million.
| Market Cap | 97.22M |
| Enterprise Value | 151.49M |
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OptiNose has 10.13 million shares outstanding. The number of shares has increased by 49.39% in one year.
| Current Share Class | 10.13M |
| Shares Outstanding | 10.13M |
| Shares Change (YoY) | +49.39% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 5.36% |
| Owned by Institutions (%) | 39.68% |
| Float | 6.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.31 |
| Forward PS | 1.14 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.64
| Current Ratio | 0.64 |
| Quick Ratio | 0.55 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.79 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -9.97% |
| Return on Invested Capital (ROIC) | -19.98% |
| Return on Capital Employed (ROCE) | 26.32% |
| Revenue Per Employee | $639,500 |
| Profits Per Employee | -$233,516 |
| Employee Count | 128 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 0.72 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.21% in the last 52 weeks. The beta is -0.89, so OptiNose's price volatility has been lower than the market average.
| Beta (5Y) | -0.89 |
| 52-Week Price Change | -49.21% |
| 50-Day Moving Average | 8.75 |
| 200-Day Moving Average | 9.12 |
| Relative Strength Index (RSI) | 72.36 |
| Average Volume (20 Days) | 71,189 |
Short Selling Information
The latest short interest is 132,651, so 1.31% of the outstanding shares have been sold short.
| Short Interest | 132,651 |
| Short Previous Month | 142,207 |
| Short % of Shares Out | 1.31% |
| Short % of Float | 2.10% |
| Short Ratio (days to cover) | 1.38 |
Income Statement
In the last 12 months, OptiNose had revenue of $81.86 million and -$29.89 million in losses. Loss per share was -$2.67.
| Revenue | 81.86M |
| Gross Profit | 74.11M |
| Operating Income | -15.83M |
| Pretax Income | -40.91M |
| Net Income | -29.89M |
| EBITDA | -15.57M |
| EBIT | -15.83M |
| Loss Per Share | -$2.67 |
Balance Sheet
The company has $72.93 million in cash and $127.21 million in debt, giving a net cash position of -$54.27 million or -$5.36 per share.
| Cash & Cash Equivalents | 72.93M |
| Total Debt | 127.21M |
| Net Cash | -54.27M |
| Net Cash Per Share | -$5.36 |
| Equity (Book Value) | -61.37M |
| Book Value Per Share | -6.06 |
| Working Capital | -63.00M |
Cash Flow
In the last 12 months, operating cash flow was -$34.21 million and capital expenditures -$50,000, giving a free cash flow of -$34.26 million.
| Operating Cash Flow | -34.21M |
| Capital Expenditures | -50,000 |
| Free Cash Flow | -34.26M |
| FCF Per Share | -$3.38 |
Margins
Gross margin is 90.53%, with operating and profit margins of -19.34% and -36.52%.
| Gross Margin | 90.53% |
| Operating Margin | -19.34% |
| Pretax Margin | -36.52% |
| Profit Margin | -36.52% |
| EBITDA Margin | -19.02% |
| EBIT Margin | -19.34% |
| FCF Margin | n/a |
Dividends & Yields
OptiNose does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -49.39% |
| Shareholder Yield | -49.39% |
| Earnings Yield | -30.74% |
| FCF Yield | -35.24% |
Analyst Forecast
The average price target for OptiNose is $9.00, which is -6.25% lower than the current price. The consensus rating is "Hold".
| Price Target | $9.00 |
| Price Target Difference | -6.25% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 23.94% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 31, 2024. It was a reverse split with a ratio of 0.0666667:1.
| Last Split Date | Dec 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0666667:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |